Almirall, a global pharma company dedicated to medical dermatology, is leading innovation in skin health to transform people’s lives.
Almirall is a global pharma company dedicated to medical dermatology. Their heritage, coupled with a deep scientific understanding of skin diseases, patients, and dermatologists are the foundation for delivering new and impactful treatments for skin diseases that help to transform people’s lives. Almirall´s focus on science, innovation, and its long-term view of its contributions to people living with skin diseases and to society have made the company a valued contributor to the dermatology community.
With a vision of 360° patient care in dermatology, Almirall deeply understands patients and responds to their unmet needs, both the physical symptoms, as well as the severe impact on mental health and well-being that patients with skin diseases can experience…
Almirall’s journey began in 1944 with the mission to provide people access to impactful medicines. That mission has evolved into a steadfast commitment to transforming treatment paradigms in dermatology by delivering innovative solutions that address the diverse needs of people with skin diseases. Grounded in science, Almirall constantly advances the understanding of skin biology and skin diseases.
At the forefront of Almirall’s approach is a holistic view of people’s needs. Recognizing that dermatological conditions often have far-reaching effects on people’s lives beyond the physical symptoms, Almirall’s research efforts include the assessment of the emotional, psychological, and psychosocial impact on patients’ lives. This comprehensive understanding drives the development of medicines to treat patients’ symptoms and improve their overall quality of life.
Almirall’s collaborative research and development approach, involving leading scientists, healthcare professionals, and patients, ensures that innovations are based on relevant insights and utilize the advancements of science and technology. These collaborations have enabled them to conduct numerous studies in immunoinflammatory diseases such as psoriasis and atopic dermatitis, as well as other broad skin conditions like acne and actinic keratosis. These diseases often have a significant effect on the overall wellbeing and daily life of patients. In addition to interventional clinical studies, Almirall expands its research focus on understanding in real-world conditions the impact of a holistic approach of people-centered healthcare.
In addition to their focus on patient care, Almirall is committed to advancing the fields of dermatology, skin science, and technology development. Through investments in research, education, and advocacy, the company seeks to raise awareness about the impact of dermatological conditions and promote greater understanding and acceptance within the medical community.
Almirall has a team of nearly 2000 people and a portfolio of over 50 dermatology products in more than 100 countries. Looking ahead, with a strong foundation in science, a commitment to collaboration, and a focus on innovation, the company is well-positioned to continue to lead in addressing the holistic needs of patients with dermatological conditions. Investments in cutting-edge technologies, such as AI-based drug discovery and mRNA, underscore Almirall’s commitment to pushing the boundaries of innovation in dermatology. Almirall’s long-term view and leadership in innovation will continue to lead to the development of meaningful treatments for people with skin conditions, helping them realize their hopes and dreams for a healthy life.
Find out more about Global Health campaign
